Clinical Trial Update: Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing methotrexate to triamcinolone periocular injections for thyroid-associated orbitopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Associated Orbitopathy

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Cairo University | Conditions: Thyroid Associated Orbitopathy | Phase 2 | Status: COMPLETED